Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
3.
JAMA Intern Med ; 179(11): 1459-1460, 2019 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-31479114
4.
J Gen Intern Med ; 34(7): 1330-1333, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-31044409

RESUMEN

Despite the strict prohibition against all forms of sexual relations between physicians and their patients, some physicians cross this bright line and abuse their patients sexually. The true extent of sexual abuse of patients by physicians in the U.S. health care system is unknown. An analysis of National Practitioner Data Bank reports of adverse disciplinary actions taken by state medical boards, peer-review sanctions by institutions, and malpractice payments shows that a very small number of physicians have faced "reportable" consequences for this unethical behavior. However, physician self-reported data suggest that the problem occurs at a higher rate. We discuss the factors that can explain why such sexual abuse of patients is a persistent problem in the U.S. health care system. We implore the medical community to begin a candid discussion of this problem and call for an explicit zero-tolerance standard against sexual abuse of patients by physicians. This standard must be coupled with regulatory, institutional, and cultural changes to realize its promise. We propose initial recommendations toward that end.


Asunto(s)
Mala Praxis/legislación & jurisprudencia , National Practitioner Data Bank/legislación & jurisprudencia , Relaciones Médico-Paciente , Médicos/legislación & jurisprudencia , Delitos Sexuales/legislación & jurisprudencia , Femenino , Humanos , Masculino , Médicos/normas , Mala Conducta Profesional/legislación & jurisprudencia , Delitos Sexuales/prevención & control , Estados Unidos/epidemiología
5.
Public Health Nurs ; 36(2): 109-117, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30556923

RESUMEN

OBJECTIVE: The objective of this study was to examine nurse sexual-misconduct-related reports in the National Practitioner Data Bank (NPDB) and to compare them with reports for other types of offenses. DESIGN AND POPULATION: We analyzed NPDB's reports of adverse state nursing board licensure actions and malpractice payments for all nurses from January 1, 2003, to June 30, 2016. RESULTS: Overall, 882 nurses had sexual-misconduct-related reports. Most were aged 35-54 (63.2%), male (63.2%), and registered or advanced practice nurses (61.5%). The disciplinary actions noted in the 988 nurse sexual-misconduct-related licensure reports were more frequently serious than those noted in the 207,023 reports for other offenses committed by nurses (90.8% vs. 74.8%, respectively; p < 0.001). Of the 33 nurses with sexual-misconduct-related malpractice-payment reports, 48.5% were not disciplined by any state board of nursing for these offenses. Three-quarters of the victims in the 47 sexual-misconduct-related malpractice-payment reports were female, with "emotional injury only" reported as the severity of injury in 91.5% of these reports. CONCLUSIONS: Very few nurses have been reported to the NPDB due to sexual misconduct. We welcome a zero-tolerance standard against sexual misconduct involving patients by all types of health care professionals, including nurses.


Asunto(s)
Relaciones Enfermero-Paciente , Mala Conducta Profesional/estadística & datos numéricos , Delitos Sexuales/estadística & datos numéricos , Conducta Sexual/estadística & datos numéricos , Adulto , Confidencialidad , Femenino , Humanos , Masculino , Mala Praxis/estadística & datos numéricos , Persona de Mediana Edad , National Practitioner Data Bank , Estados Unidos
8.
PLoS One ; 11(5): e0155005, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27191961

RESUMEN

OBJECTIVE: The adequacy of informed consent in the Surfactant, Positive Pressure, and Pulse Oximetry Randomized Trial (SUPPORT) has been questioned. SUPPORT investigators and publishing editors, heads of government study funding agencies, and many ethicists have argued that informed consent was adequate because the two oxygen saturation target ranges studied fell within a range commonly recommended in guidelines. We sought to determine whether each oxygen target as studied in SUPPORT and four similar randomized controlled trials (RCTs) was consistent with usual care. DESIGN/PARTICIPANTS/SETTING: PubMed, EMBASE, Web of Science, and Scopus were searched for English articles back to 1990 providing information on usual care oxygen management in extremely premature infants. Data were extracted on intended and achieved oxygen saturation levels as determined by pulse oximetry. Twenty-two SUPPORT consent forms were examined for statements about oxygen interventions. RESULTS: While the high oxygen saturation target range (91 to 95%) was consistent with usual care, the low range (85 to 89%) was not used outside of the SUPPORT trial according to surveys and clinical studies of usual care. During usual care, similar lower limits (< 88%) were universally paired with higher upper limits (≥ 92%) and providers skewed achieved oxygen saturations toward the upper-end of these intended ranges. Blinded targeting of a low narrow range resulted in significantly lower achieved oxygen saturations and a doubling of time spent below the lower limit of the intended range compared to usual care practices. The SUPPORT consent forms suggested that the low oxygen saturation arm was a widely practiced subset of usual care. CONCLUSIONS: SUPPORT does not exemplify comparative effectiveness research studying practices or therapies in common use. Descriptions of major differences between the interventions studied and commonly practiced usual care, as well as potential risks associated with these differences, are essential elements of adequate informed consent.


Asunto(s)
Recien Nacido Extremadamente Prematuro , Consentimiento Informado de Menores/normas , Cuidado Intensivo Neonatal/normas , Oximetría/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Adulto , Humanos , Recién Nacido , Cuidado Intensivo Neonatal/legislación & jurisprudencia , Oximetría/normas
9.
PLoS One ; 11(2): e0147800, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26840639

RESUMEN

BACKGROUND: Little information exists on U.S. physicians who have been disciplined with licensure or restriction-of-clinical-privileges actions or have had malpractice payments because of sexual misconduct. Our objectives were to: (1) determine the number of these physicians and compare their age groups' distribution with that of the general U.S. physician population; (2) compare the type of disciplinary actions taken against these physicians with actions taken against physicians disciplined for other offenses; (3) compare the characteristics and type of injury among victims of these physicians with those of victims in reports for physicians with other offenses in malpractice-payment reports; and (4) determine the percentages of physicians with clinical-privileges or malpractice-payment reports due to sexual misconduct who were not disciplined by medical boards. METHODS AND RESULTS: We conducted a cross-sectional analysis of physician reports submitted to the National Practitioner Data Bank (NPDB) from January 1, 2003, through September 30, 2013. A total of 1039 physicians had ≥ 1 sexual-misconduct-related reports. The majority (75.6%) had only licensure reports, and 90.1% were 40 or older. For victims in malpractice-payment reports, 87.4% were female, and "emotional injury only" was the predominant type of injury. We found a higher percentage of serious licensure actions and clinical-privileges revocations in sexual-misconduct-related reports than in reports for other offenses (89.0% vs 68.1%, P = < .001, and 29.3% vs 18.8%, P = .002, respectively). Seventy percent of the physicians with a clinical-privileges or malpractice-payment report due to sexual misconduct were not disciplined by medical boards for this problem. CONCLUSIONS: A small number of physicians were reported to the NPDB because of sexual misconduct. It is concerning that a majority of the physicians with a clinical-privileges action or malpractice-payment report due to sexual misconduct were not disciplined by medical boards for this unethical behavior.


Asunto(s)
National Practitioner Data Bank , Médicos , Mala Conducta Profesional , Conducta Sexual , Adolescente , Adulto , Anciano , Niño , Preescolar , Víctimas de Crimen , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , National Practitioner Data Bank/estadística & datos numéricos , Médicos/estadística & datos numéricos , Mala Conducta Profesional/estadística & datos numéricos , Estudios Retrospectivos , Estados Unidos , Adulto Joven
14.
Health Aff (Millwood) ; 33(8): 1453-9, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25092848

RESUMEN

After approval, many prescription medications that patients rely on subsequently receive new black-box warnings or are withdrawn from the market because of safety concerns. We examined whether the frequency of these safety problems has increased since 1992, when the Prescription Drug User Fee Act, legislation designed to accelerate the drug approval process at the Food and Drug Administration, was passed. We found that drugs approved after the act's passage were more likely to receive a new black-box warning or be withdrawn than drugs approved before its passage (26.7 per 100.0 drugs versus 21.2 per 100.0 drugs at up to sixteen years of follow-up). We could not establish causality, however. Our findings suggest the need for reforms to reduce patients' exposure to unsafe drugs, such as a statement or symbol in the labeling, medication guides for patients, and marketing materials indicating that a drug was approved only recently.


Asunto(s)
Sistemas de Registro de Reacción Adversa a Medicamentos/estadística & datos numéricos , Aprobación de Drogas , Etiquetado de Medicamentos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Recall y Retirada del Producto , United States Food and Drug Administration , Aprobación de Drogas/legislación & jurisprudencia , Femenino , Humanos , Legislación de Medicamentos/normas , Masculino , Seguridad del Paciente , Medicamentos bajo Prescripción , Factores de Tiempo , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA